1 month ago | 
onlinelibrary.wiley.com | Yang Zhang |Zhi-Hao Wang |Wenbo Li |Yu Tang
Conflict of Interests The authors declare no conflict of interest. Supporting Information Filename Description anie202508114-sup-0001-SuppMat.docx14.6 MB Supporting Information References 1, , , , , , , , , , , , , , , , Nature 2021, 598, 304–307. 2, , , , , Chem. Soc. Rev. 2022, 51, 3561–3608. 3, , Chem. Rev. 2020, 120, 919–985. 4, , Nature 1972, 238, 37–38. 5, , , , , Nat. Catal. 2018, 1, 291–299. 6, , , Angew. Chem. Inter. Ed. 2022, 61, e202117567.
1 month ago | 
arxiv.org | Long Peng |Xin Di |Yong Guo |Wenbo Li
Work on one of the world's most important websites and make an impact on open science.
1 month ago | 00183-9?rss=yes&sz=64)
cell.com | Zilong Zhao |Benxia Hu |Yalan Deng |Melinda Soeung |Jun Yao |Lanxin Bei | +25 more
Keywords sickle cell disease renal medullary carcinoma ferroptosis genomic architecture alteration Hi-C H2S SLC7A11 SMARCB1 immune checkpoint inhibitors CD8+ T cells Introduction Sickle cell disease (SCD), the most prevalent inherited blood disorder,1 arises from the homozygous HbS mutation (GAG>GTG: βGlu6Val), causing hemoglobin abnormalities that make red blood cells (RBCs) assume a sickle or crescent shape.2 Individuals with SCD have RBCs prone to hemolysis, leading to vaso-occlusive...
1 month ago | 00183-9&sz=64)
cell.com | Zilong Zhao |Benxia Hu |Yalan Deng |Melinda Soeung |Jun Yao |Lanxin Bei | +25 more
Keywords sickle cell disease renal medullary carcinoma ferroptosis genomic architecture alteration Hi-C H2S SLC7A11 SMARCB1 immune checkpoint inhibitors CD8+ T cells Introduction Sickle cell disease (SCD), the most prevalent inherited blood disorder,1 arises from the homozygous HbS mutation (GAG>GTG: βGlu6Val), causing hemoglobin abnormalities that make red blood cells (RBCs) assume a sickle or crescent shape.2 Individuals with SCD have RBCs prone to hemolysis, leading to vaso-occlusive...
2 months ago | 
advanced.onlinelibrary.wiley.com | Chunlei Zhang |Ming Wang |Wenbo Li |Wenran Zhang
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202504693-sup-0001-SuppMat.docx1.2 MB Supporting Information adfm202504693-sup-0002-MovieS1.mp43.5 MB Supplemental Movie 1 References 1, , , , , , , , , , Nat. Commun. 2024, 15, 8516. 2, , , , , , , Renew. Sustain. Energy Rev. 2023, 187, 113723. 3, , , , , , , , , , , , , , , , , , , , Adv. Mater. 2023, 35, 2209119. 4, , , , , , , , , , , , , , , Nat. Commun.
2 months ago | 
tandfonline.com | Wenbo Li |Shan Xu
About Your PrivacyWe process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the link under each purpose.
pubs.acs.org | Xuan Tang |Yanzhao Gao |Wenbo Li |Sheng Dai
dx.doi.org | Xuan Tang |Yanzhao Gao |Wenbo Li |Sheng Dai
arxiv.org | Wenbo Li |Shiyi Wang |Huiping Zhuang |Qingyao Wu
biorxiv.org | Chenwang Zhang |Nan Liang |Wenbo Li |Shuai Xu